The Women's International Study of Long-duration Oestrogen after Menopause (WISDOM): A randomised controlled trial

BMC Women's Health

Volumn 7, Issue , 2007, Pages

  Vickers, Madge R ^a   Martin, Jeannett ^a   Meade, Tom W ^b   Arasaratnum, N ^a   Collins, N ^a   Furness, P ^a   Ghali, M ^a   Gordon, E ^a   Huppert, F ^a   Islam, Z ^a   Knott, C ^a   Meredith, S ^a   Prince, M ^a   Purdon, S ^a   Richards, M ^a   Taylor, L ^a   Welton, A ^a   Zhu, C Q ^a   Zuhrie, R ^a   Dowell, A ^a   Lawton, B ^a   MacLennon, A ^a   more..

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE; PLACEBO; PREMIQUE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEMENTIA; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HEALTH CARE COST; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SPOTTING; TREATMENT DURATION; VAGINA BLEEDING; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

EID: 33947493091     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-7-2     Document Type: Article

References (63)

1. Kiel DP Felson DT Andersen JJ Wilson PW Moskowitz MA Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study n Eng J Med 1987 317 1169-1174
2. Stampfer MJ Colditz GA Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence Prev Med 1991 20 47-63 10.1016/0091-7435(91)90006-P 1826173
3. Theriault RL Hormone replacement therapy and breast cancer: An overview Br J Ob Gyn 1996 103 Suppl 13 87-91
4. Cramer DW Knapp RC Review of epidemiologic studies of endometrial cancer and exogenous estrogen Obstet Gynecol 1979 54 521-527 492641
5. Grady D Rubin SM Pettiti DB Fox Cs Black D Ettinger B Ernster VL Cummings SR Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 1992 117 1016-1037 1443971
6. Meade TW Berra A Hormone replacement therapy and cardiovascular disease Br Med Bull 1992 48 276-308 1450872
7. Stampfer MJ Colditz GA Willett WC Manson JE Rosner B Speizer FE Hennekens CH Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow-up from the Nurses' Health Study N Eng J Med 1991 325 756-762
8. The Writing Group for the PePI trial Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 1995 273 199-208 10.1001/jama.273.3.199 7807658
9. Wilkes HC Meade TW Hormone replacement therapy in general practice: A survey of doctors in the MRC's general practice research framework BMJ 1991 302 1317-20 1670009 2059689
10. Medical Research Council's General Practice Research Framework Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy BMJ 1996 312 473-478 8597678
11. Gallagher JC Kable WT Goldar D Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen Am J Med 1991 90 171-178 1847582
12. Tang M Jacobs D Stern Y Marder K Schofield P Gurland B Andrews H Mayeux R Effect of oestrogen during menopause on risk and age at outset of Alzheimer's disease Lancet 1996 348 429-432 10.1016/ S0140-6736(96)03356-9 8709781
13. Kawas C Resnick S Morrison A Brookmeyer R Corrada M Zonderman A Bacal C Lingle DD Metter C A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. The Baltimore Longitudinal Study of Aging Neurology 1997 48 1517-1521 9191758
14. Paganini-Hill A The Benefits of Estrogen Replacement Therapy on Oral Health Arch Int Med 1995 155 21 2325-2329 10.1001/archinte.155.21.2325
15. Payne JB Zachs NR Reinhardt RA Nummikoski PV Patil KD The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis Periodontology 1997 68 24-31
16. Forabosco A Criscuolo M Coukos G Ucelli E Weinstein R Spinato S Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort Oral Surgery, Oral Medicine, Oral Pathology 1992 73 570-574 10.1016/0030-4220(92)90100-5
17. Felson DT Zhang Y Hannan MT Naimark A Weissman BN Aliabadi P Levy D The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study Arthritis Rheum 1995 38 10 1500 5 10.1002/art.1780381017 7575700
18. Nevitt MC Cummings SR Lane NE Hochberg MC Scott Jc Pressman AR Genant HK Cauley JA Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women Arch Intern Med 1996 156 2073-2080 10.1001/archinte.156.18.2073 8862099
19. Risch HA Howe GR Menopausal hormone use and colorectal cancer in Saskatchewan: A record linkage cohort study Cancer Epidemiology, Biomarkers & Prevention 1995 4 21-28
20. Fernandez E La Vecchia C D'Avanzo B Franceschi S Negri E Parazzini F Oral contraceptives, hormone replacement therapy and risk of colorectal cancer Brit J Cancer 1996 73 1431-1435 8645593
21. Klein BE Klein R Jensen SC Ritter LL Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study Trans Am Ophthalmol Soc 1994 92 289-295 1298512 7886868
22. Benitez del Castillo JM del Rio T Garcia-Sanchez J Effects of estrogen use on lens transmittance in postmenopausal women Ophthamology 1997 104 970-973
23. Daly E Vessey MP Hawkins MM Carson JL Gough P Marsh S Risk of venous thromboembolism in users of hormone replacement therapy Lancet 1996 348 977-980 10.1016/S0140-6736(96)07113-9 8855852
24. Jick H Derby LE Myers MW Vasilakis C Newton KM Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 1996 348 981 983 10.1016/ S0140-6736(96)07114-0 8855853
25. Daly E Vessey MP Painter R Hawkins MM Case control study of venous thromboembolism risk in users of hormone replacement therapy Lancet 1996 348 1027 10.1016/S0140-6736(96)24041-3 8855869
26. Gutthann SP Rodriguez LAG Castellsague J Oliart AD Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study BMJ 1997 314 796-800 9081000
27. Grodstein F Stampfer MJ Goldhaber SZ Manson JE Colditz GA Speizer FE Willett WC Hennekens CH Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 1996 348 983-987 10.1016/ S0140-6736(96)07308-4 8855854
28. Risch HA Estrogen replacement therapy and risk of epithelial ovarian cancer Gynecol Oncol 1996 63 254-257 10.1006/gyno.1996.0315 8910636
29. Strachan D Sudden sensorineural deafness and hormone replacement therapy J Laryngol Otol 1996 110 1148-1150 9015429
30. Cutolo M Sulli A Seriolo S Accardo S Masi AT Estrogens, the immune response and autoimmunity Clin Exp Rheumatology 1995 13 217-226
31. Ettinger B Friedman GD Bush T Quesenberry CP Jr Reduced mortality associated with long-term postmenopausal estrogen therapy Obstet Gynecol 1996 87 6-12 10.1016/0029-7844(95)00358-4 8532268
32. Grodstein F Stampfer MJ Colditz GA Willett WC Manson JE Joffe M Rosner B Fuchs C Hankinson SE Hunter DJ Hennekens CH Speizer FE Postmenopausal hormone therapy and mortality N Eng J Med 1997 336 1769-1775 10.1056/ NEJM199706193362501
33. Doll R Peto R Randomised controlled trials and retrospective controls BMJ 1980 280 44 1600504 7357264
34. Vickers M The MRC long-term randomised controlled trial of hormone replacement therapy: Background, design and objectives J British Menopause Soc 1996 1 9-13
35. The Women's Health Initiative Study Group Design of the Women's Health Initiative Clinical trial and Observational Study Controlled Clinical Trials 1998 19 61-109 9492970
36. Hulley S Grady D Bush T Furberg C Herrington D Riggs B Vittinghoff E for the Heart and Estrogen/progestin Replacement Study Research Group Randomized trial of estrogen plus progestin for secondary prevention of - coronary heart disease in postmenopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group JAMA 1998 280 7 605-613 10.1001/jama.280.7.605 9718051
37. Hoibraaten E Qvigstad E Arnesen H Larsen S Wickstrom E Sandset PM Increased risk of recurrent venous thromboembolism during hormone replacement therapy. Results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 2000 84 961-967
38. Viscoli CM Brass LM Kernan WN Sarrel PM Suissa S Horwitz RI A clinical trial of estrogen -replacement therapy after ischemic stroke New Eng J Med 2001 345 1243-1249 10.1056/NEJMoa010534 11680444
39. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial JAMA 2002 288 321-333 10.1001/jama.288.3.321 12117397
40. Shumaker S Legault C Kuller L Rapp S Thal L Lane D Fillit H Stefanick M Hendrix S Lewis C Masaki K Cocker L Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women. Women's Health Initiative Memory Study JAMA 2004 291 2947-2958 10.1001/jama.291.24.2947 15213206
41. Hays J Ockene JK Brunner RL Shumaker SA Brzyski RG LaCroix AZ Granek IA Valanis BG for the Womens Health Initiative investigators Effects of estrogen plus progestin on health related quality of life N Eng J Med 2003 348 1839-54 10.1056/NEJMoa030311
42. Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomised Controlled Trial JAMA 2004 291 1701-1712 10.1001/jama.291.14.1701 15082697
43. 5Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer Lancet 1997 350 1047-1059 10.1016/ S0140-6736(97)08233-0 10213546
44. Million Women Study collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 2003 362 9382 419 427 10.1016/ S0140-6736(03)14065-2 12927427
45. Grodstein F Manson JE Colditz GA Willett WC Speizer FE Stampfer MJ A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease Ann Intern Med 2000 133 933-41 11119394
46. Grodstein F Manson JE Stampfer MJ Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study: A prospective, observational study Ann Intern Med 2001 135 1-8 11434726
47. Committee on Safety of Medicines HRT:uPdate on the risk of breast cancer and long term safety Current Problems in Pharmacovigilanc 2003 29 1-3
48. The European Agency for the Evaluation of Medical Products EMEA public statement on recent publications regarding hormone replacement therapy http://www.emea.europa.eu/pdfs/human/press/pus/3306503en.pdf 3 December 2003
49. US Food and Drug Administration The estrogen and progestin dilemma: New advice, labelling guidelines http://www.fda.gov/fdac/features/2003/ 203_estrogen.html
50. MacLennon AH Sturdee DW WHI, WHI, WHI? Climacteric 2004 7 221-4 10.1080/ 13697130400001331 15669545
51. Salpeter S Mortality associated with hormone replacement therapy in younger and older women J Gen Intern Med 2004 19 791-804 1492478 15209595 10.1111/j.1525-1497.2004.30281.x
52. Bellamy N Buchanan WW Goldsmith CH Campbell J Stitt L Validation study of WOMAC: A health ststus instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee The Journal of rheumatology 1988 15 1833-40 3068365
53. Bellamy N Campbell J Haraoui B Gerecz-Simon E Buchbinder R Hobby K MacDermid JC Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: An evaluation of reliability, validity and responsiveness Osteoarthritis Cartilage 2002 10 11 863-9 10.1053/joca.2002.0838 12435331
54. Radloff LS The CES-D Scale: A self-report depression scale for research in the general population Applied Psychological Measurement 1977 1 3 385-401
55. Petitti DB Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription J Gerontol A Biol Sci Med Sci 2002 57 532-538
56. Hyland ME Sodergren SC Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales Quality of Life Research 1996 5 469-480 10.1007/BF00540019 8973126
57. Hunter M The women's health questionnaire: A measure of mid-aged women's perceptions of their emotional and physical health Psychology and Health 1992 7 45-54
58. Liao KL-M Hunter M Weinman J Health-related behaviours and their correlates in a general population sample of 45-year old women Psychology and Health 1995 10 171-184
59. EuroQol Group EUROQOL: A new facility for the measurement of health related quality of life Health Policy 1990 16 199-208 10.1016/ 0168-8510(90)90421-9 10109801
60. Hickey AM Bury G O'Boyle CA Bradley F O'Kelly FD Shannon W A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS BMJ 1996 313 29-33 8664768
61. Ware JE Sherbourne C The MOS 36-item short-form health survey (SF 36). 1. Conceptual framework and item selection Medical Care 1992 30 6 473-483 10.1097/00005650-199206000-00002 1593914
62. Collett D Modelling Survival Data in Medical Research Chapman and Hall 1994
63. Vickers M Meade T Darbyshire J WISDOM: History and early demise - was it inevitable? Climacteric 2002 5 317-325 12626209